419 related articles for article (PubMed ID: 19881538)
1. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.
Zhu K; Dunner K; McConkey DJ
Oncogene; 2010 Jan; 29(3):451-62. PubMed ID: 19881538
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
Kao C; Chao A; Tsai CL; Chuang WC; Huang WP; Chen GC; Lin CY; Wang TH; Wang HS; Lai CH
Cell Death Dis; 2014 Nov; 5(11):e1510. PubMed ID: 25375375
[TBL] [Abstract][Full Text] [Related]
3. Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression.
Zhu K; Chan W; Heymach J; Wilkinson M; McConkey DJ
Cancer Res; 2009 Mar; 69(5):1836-43. PubMed ID: 19244104
[TBL] [Abstract][Full Text] [Related]
4. An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells.
Yao F; Wang G; Wei W; Tu Y; Tong H; Sun S
Mol Med Rep; 2012 Jan; 5(1):84-8. PubMed ID: 21931937
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors activate autophagy involving inhibition of PI3K-Akt-mTOR pathway as an anti-oxidation defense in human RPE cells.
Tang B; Cai J; Sun L; Li Y; Qu J; Snider BJ; Wu S
PLoS One; 2014; 9(7):e103364. PubMed ID: 25062253
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.
Pandit B; Gartel AL
Cell Cycle; 2011 Oct; 10(19):3269-73. PubMed ID: 21941087
[TBL] [Abstract][Full Text] [Related]
9. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation.
Harada M; Hanada S; Toivola DM; Ghori N; Omary MB
Hepatology; 2008 Jun; 47(6):2026-35. PubMed ID: 18454506
[TBL] [Abstract][Full Text] [Related]
10. Targeting the proteasome pathway.
Tsukamoto S; Yokosawa H
Expert Opin Ther Targets; 2009 May; 13(5):605-21. PubMed ID: 19397479
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
[TBL] [Abstract][Full Text] [Related]
12. MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.
Jagannathan S; Vad N; Vallabhapurapu S; Vallabhapurapu S; Anderson KC; Driscoll JJ
Leukemia; 2015 Mar; 29(3):727-38. PubMed ID: 25234165
[TBL] [Abstract][Full Text] [Related]
13. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).
Fujita E; Kouroku Y; Isoai A; Kumagai H; Misutani A; Matsuda C; Hayashi YK; Momoi T
Hum Mol Genet; 2007 Mar; 16(6):618-29. PubMed ID: 17331981
[TBL] [Abstract][Full Text] [Related]
14. Proteaphagy in Mammalian Cells Can Function Independent of ATG5/ATG7.
Goebel T; Mausbach S; Tuermer A; Eltahir H; Winter D; Gieselmann V; Thelen M
Mol Cell Proteomics; 2020 Jul; 19(7):1120-1131. PubMed ID: 32299840
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
Yerlikaya A; DoKudur H
Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8.
Laussmann MA; Passante E; Düssmann H; Rauen JA; Würstle ML; Delgado ME; Devocelle M; Prehn JH; Rehm M
Cell Death Differ; 2011 Oct; 18(10):1584-97. PubMed ID: 21455219
[TBL] [Abstract][Full Text] [Related]
17. Novel proteasome inhibitors to overcome bortezomib resistance.
Ruschak AM; Slassi M; Kay LE; Schimmer AD
J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
Raaben M; Posthuma CC; Verheije MH; te Lintelo EG; Kikkert M; Drijfhout JW; Snijder EJ; Rottier PJ; de Haan CA
J Virol; 2010 Aug; 84(15):7869-79. PubMed ID: 20484504
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro.
Peron M; Bonvini P; Rosolen A
BMC Cancer; 2012 Jun; 12():233. PubMed ID: 22691173
[TBL] [Abstract][Full Text] [Related]
20. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
